Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ory

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Oncotarget|March 26, 2011
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunityBenjamin Ory, Leif W Ellisen
International Journal of Cancer|March 30, 2006
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survivalFrançois Gouin, Benjamin Ory, François Rédini, et al.
Current Medicinal Chemistry|June 23, 2007
mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumoursBenjamin Ory, Gatien Moriceau, Francoise Redini, et al.
Trends in Molecular Medicine|July 10, 2004
Bisphosphonates: new therapeutic agents for the treatment of bone tumorsDominique Heymann, Benjamin Ory, François Gouin, et al.
Clinical Chemistry|February 21, 2016
Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and IsolationMarta Tellez Gabriel, Lidia Rodriguez Calleja, Antoine Chalopin, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ HybridizationBrice Moukengue, Jérôme Amiaud, Camille Jacques, et al.
Cancers|February 11, 2021
Mechanisms of Resistance to Conventional Therapies for OsteosarcomaLouise Marchandet, Morgane Lallier, Céline Charrier, et al.
Molecular and Cellular Biology|September 8, 2011
Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage responseDouangsone D Vadysirisack, Franziska Baenke, Benjamin Ory, et al.
International Journal of Molecular Sciences|December 22, 2016
Tumour Heterogeneity: The Key Advantages of Single-Cell AnalysisMarta Tellez-Gabriel, Benjamin Ory, Francois Lamoureux, et al.
Cancer Research|April 30, 2011
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinomaMatthew R Ramsey, Lei He, Nicole Forster, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Oncotarget|March 26, 2011
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunityBenjamin Ory, Leif W Ellisen
International Journal of Cancer|March 30, 2006
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survivalFrançois Gouin, Benjamin Ory, François Rédini, et al.
Current Medicinal Chemistry|June 23, 2007
mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumoursBenjamin Ory, Gatien Moriceau, Francoise Redini, et al.
Trends in Molecular Medicine|July 10, 2004
Bisphosphonates: new therapeutic agents for the treatment of bone tumorsDominique Heymann, Benjamin Ory, François Gouin, et al.
Clinical Chemistry|February 21, 2016
Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and IsolationMarta Tellez Gabriel, Lidia Rodriguez Calleja, Antoine Chalopin, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ HybridizationBrice Moukengue, Jérôme Amiaud, Camille Jacques, et al.
Cancers|February 11, 2021
Mechanisms of Resistance to Conventional Therapies for OsteosarcomaLouise Marchandet, Morgane Lallier, Céline Charrier, et al.
Molecular and Cellular Biology|September 8, 2011
Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage responseDouangsone D Vadysirisack, Franziska Baenke, Benjamin Ory, et al.
International Journal of Molecular Sciences|December 22, 2016
Tumour Heterogeneity: The Key Advantages of Single-Cell AnalysisMarta Tellez-Gabriel, Benjamin Ory, Francois Lamoureux, et al.
Cancer Research|April 30, 2011
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinomaMatthew R Ramsey, Lei He, Nicole Forster, et al.
Pageof 6